MedTrace Logo

Five Year Oncological Outcome After CME for Right-sided Colon Cancer

NCT03754075 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1069

Last updated 2019-03-13

No results posted yet for this study

Summary

Study based on existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III right-sided colon cancer.

Conditions

  • Colonic Neoplasms

Interventions

PROCEDURE

Complete mesocolic excision

The resection was based on the principles of CME. The superior mesenteric vein was exposed to perform central vessel ligation and lymph nodes dissection. Extended right hemicolectomies for tumors located from the ascending colon close to the hepatic flexure and distally were performed openly as standard during the study period. These resections included the prepyloric and gastroepiploic lymph nodes dissection.

PROCEDURE

Conventional colon resections

The patients underwent what was considered standard colon cancer resections in Denmark during the study period.

Sponsors & Collaborators

  • Bispebjerg Hospital

    collaborator OTHER

  • Hvidovre University Hospital

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Zealand University Hospital

    collaborator OTHER

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Claus A Bertelsen, PhD, MD · Nordsjaellands Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-01
Primary Completion
2019-01-31
Completion
2019-03-16

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754075 on ClinicalTrials.gov